BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -30.12% |
| Q3 2025 | -2.85% |
| Q2 2025 | -15.21% |
| Q1 2025 | -1.44% |
| Q4 2024 | -0.09% |
| Q3 2024 | 2.49% |
| Q2 2024 | -0.63% |
| Q1 2024 | 0.21% |
| Q4 2023 | -2.40% |
| Q3 2023 | 2.15% |
| Q2 2023 | 9.57% |
| Q1 2023 | 1.88% |
| Q4 2022 | 2.72% |
| Q3 2022 | 372.24% |
| Q2 2022 | -75.07% |
| Q1 2022 | 3.33% |
| Q4 2021 | 251.99% |
| Q3 2021 | 4.11% |
| Q2 2021 | 2.50% |
| Q1 2021 | -43.50% |
| Q4 2020 | 246.03% |
| Q3 2020 | -5.51% |
| Q2 2020 | 0.28% |
| Q1 2020 | 0.69% |
| Q4 2019 | 0.15% |
| Q3 2019 | 1.92% |
| Q2 2019 | 5.18% |
| Q1 2019 | 27.54% |
| Q4 2018 | 0.21% |
| Q3 2018 | 19.36% |
| Q2 2018 | -2.86% |
| Q1 2018 | -2.76% |
| Q4 2017 | 0.37% |
| Q3 2017 | 0.66% |
| Q2 2017 | 0.41% |
| Q1 2017 | 0.41% |
| Q4 2016 | 0.47% |
| Q3 2016 | 74.68% |
| Q2 2016 | 0.63% |
| Q1 2016 | -6.04% |